Priscilla Do

1.1k total citations · 1 hit paper
18 papers, 458 citations indexed

About

Priscilla Do is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Priscilla Do has authored 18 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Oncology and 7 papers in Genetics. Recurrent topics in Priscilla Do's work include Chronic Lymphocytic Leukemia Research (7 papers), Immune Cell Function and Interaction (7 papers) and CAR-T cell therapy research (6 papers). Priscilla Do is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Immune Cell Function and Interaction (7 papers) and CAR-T cell therapy research (6 papers). Priscilla Do collaborates with scholars based in United States, India and Russia. Priscilla Do's co-authors include John C. Byrd, Natarajan Muthusamy, Kyle A. Beckwith, Brian M. Baker, Carolyn Cheney, Michael A. Caligiuri, Kami J. Maddocks, Jennifer A. Woyach, Amy J. Johnson and Amy M. Lehman and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The Journal of Immunology.

In The Last Decade

Priscilla Do

17 papers receiving 453 citations

Hit Papers

Ibrutinib treatment improves T cell number and function i... 2017 2026 2020 2023 2017 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Ibrutinib treatment improves T cell number and function in CLL patients
    2017 288 citations Meixiao Long, Kyle A. Beckwith et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Priscilla Do United States 7 231 211 210 150 92 18 458
Martin Cremer Germany 9 146 0.6× 183 0.9× 123 0.6× 179 1.2× 94 1.0× 22 406
Lucy Gong United States 11 134 0.6× 148 0.7× 294 1.4× 139 0.9× 210 2.3× 16 608
Padmaja Magadala United States 4 153 0.7× 258 1.2× 96 0.5× 186 1.2× 97 1.1× 5 393
Rodica Morariu-Zamfir United States 8 96 0.4× 104 0.5× 232 1.1× 110 0.7× 58 0.6× 15 385
Nicole Adrian Germany 8 131 0.6× 66 0.3× 323 1.5× 192 1.3× 85 0.9× 10 428
Petra Vočková Czechia 10 58 0.3× 89 0.4× 196 0.9× 118 0.8× 179 1.9× 18 385
Kenneth A. Foon United States 9 161 0.7× 182 0.9× 78 0.4× 110 0.7× 100 1.1× 12 352
Andrei Ivanov Russia 4 136 0.6× 167 0.8× 109 0.5× 170 1.1× 63 0.7× 8 340
Patrick H. van Berkel United Kingdom 9 96 0.4× 40 0.2× 393 1.9× 113 0.8× 112 1.2× 35 496
Shui‐on Leung United States 10 131 0.6× 52 0.2× 168 0.8× 124 0.8× 164 1.8× 28 472

Countries citing papers authored by Priscilla Do

Since Specialization
Citations

This map shows the geographic impact of Priscilla Do's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Priscilla Do with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Priscilla Do more than expected).

Fields of papers citing papers by Priscilla Do

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Priscilla Do. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Priscilla Do. The network helps show where Priscilla Do may publish in the future.

Co-authorship network of co-authors of Priscilla Do

This figure shows the co-authorship network connecting the top 25 collaborators of Priscilla Do. A scholar is included among the top collaborators of Priscilla Do based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Priscilla Do. Priscilla Do is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Do, Priscilla, et al.. (2023). Multicolor Light-Induced Immune Activation via Polymer Photocaged Cytokines. Biomacromolecules. 24(3). 1164–1172. 1 indexed citations
2.
Zhou, Chengjing, Priscilla Do, Greg Gibson, et al.. (2022). B-cell acute lymphoblastic leukemia promotes an immune suppressive microenvironment that can be overcome by IL-12. Scientific Reports. 12(1). 11870–11870. 12 indexed citations
3.
Kellner, Anna, Priscilla Do, Mi‐Young Lee, et al.. (2022). The adipocyte secretome inhibits T-cell activation by dampening T-cell receptor mechanotransduction. Biophysical Journal. 121(3). 314a–315a. 1 indexed citations
4.
Do, Priscilla, et al.. (2021). Engineered Cytokines for Cancer and Autoimmune Disease Immunotherapy. Advanced Healthcare Materials. 10(15). e2002214–e2002214. 24 indexed citations
5.
Do, Priscilla, et al.. (2020). Promoting anti-tumor immunity via bispecific T cell engaging cytokine (biteokine) therapy. The Journal of Immunology. 204(1_Supplement). 169.22–169.22. 1 indexed citations
6.
Do, Priscilla, et al.. (2020). Rapid Assembly and Screening of Multivalent Immune Cell-Redirecting Therapies for Leukemia. ACS Combinatorial Science. 22(10). 533–541. 6 indexed citations
7.
Do, Priscilla, Anna Kellner, Khalid Salaita, et al.. (2020). Optical Control of Cytokine Signaling via Bioinspired, Polymer-Induced Latency. Biomacromolecules. 21(7). 2635–2644. 6 indexed citations
8.
Hu, Eileen, Priscilla Do, Rajeswaran Mani, et al.. (2019). Abstract 1541: Evaluation of ROR1 targeted antibody drug conjugate in ROR1 positive leukemia. Cancer Research. 79(13_Supplement). 1541–1541. 1 indexed citations
9.
Do, Priscilla, Kyle A. Beckwith, Carolyn Cheney, et al.. (2019). Leukemic B Cell CTLA-4 Suppresses Costimulation of T Cells. The Journal of Immunology. 202(9). 2806–2816. 22 indexed citations
10.
Hu, Eileen, Priscilla Do, Rajeswaran Mani, et al.. (2017). Evaluation of ROR1 Targeted Antibody Drug Conjugates in Acute and Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma. Blood. 130. 3017–3017. 1 indexed citations
11.
Long, Meixiao, Kyle A. Beckwith, Priscilla Do, et al.. (2017). Ibrutinib treatment improves T cell number and function in CLL patients. Journal of Clinical Investigation. 127(8). 3052–3064. 288 indexed citations breakdown →
12.
Do, Priscilla, Carolyn Cheney, Farrukh T. Awan, et al.. (2017). CC-122 is more potent but transcriptionally mirrors Lenalidomide in Chronic Lymphocytic Leukemia. The Journal of Immunology. 198(Supplement_1). 120.14–120.14.
13.
Do, Priscilla, Kyle A. Beckwith, Larry Beaver, et al.. (2016). Leukemic Cell Expressed CTLA-4 Suppresses T Cells Via Down-Modulation of CD80 By Trans-Endocytosis. Blood. 128(22). 3221–3221. 3 indexed citations
14.
15.
Borbulevych, Oleg Y., Priscilla Do, & Brian M. Baker. (2010). Structures of native and affinity-enhanced WT1 epitopes bound to HLA-A0201: Implications for WT1-based cancer therapeutics. Molecular Immunology. 47(15). 2519–2524. 22 indexed citations
16.
Azcune, Itxaso, Eva Balentová, John J. Miles, et al.. (2010). Design, synthesis and evaluation of β-lactam antigenic peptide hybrids; unusual opening of the β-lactam ring in acidic media. Organic & Biomolecular Chemistry. 8(23). 5345–5345. 5 indexed citations
17.
Bowerman, Natalie A., Terence S. Crofts, Lukasz K. Chlewicki, et al.. (2009). Engineering the binding properties of the T cell receptor:peptide:MHC ternary complex that governs T cell activity. Molecular Immunology. 46(15). 3000–3008. 30 indexed citations
18.
Piepenbrink, Kurt H., Oleg Y. Borbulevych, Ruth F. Sommese, et al.. (2009). Fluorine substitutions in an antigenic peptide selectively modulate T-cell receptor binding in a minimally perturbing manner. Biochemical Journal. 423(3). 353–361. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Cremer Breakdown of academic impact, for papers by Lucy Gong Breakdown of academic impact, for papers by Padmaja Magadala Breakdown of academic impact, for papers by Rodica Morariu-Zamfir Breakdown of academic impact, for papers by Nicole Adrian Breakdown of academic impact, for papers by Petra Vočková Breakdown of academic impact, for papers by Kenneth A. Foon Breakdown of academic impact, for papers by Andrei Ivanov Breakdown of academic impact, for papers by Patrick H. van Berkel Breakdown of academic impact, for papers by Shui‐on Leung
Rankless by CCL
2026